Farnesol Has an Anti-obesity Effect in High-Fat Diet-Induced Obese Mice and Induces the Development of Beige Adipocytes in Human Adipose Tissue Derived-Mesenchymal Stem Cells

• Published in: Frontiers in pharmacology Vol. 8; p. 654
• Main Authors: Kim, Hye-Lin, Jung, Yunu, Park, Jinbong, Youn, Dong-Hyun, Kang, JongWook, Lim, Seona, Lee, Beom Su, Jeong, Mi-Young, Choe, Seong-Kyu, Park, Raekil, Ahn, Kwang Seok, Um, Jae-Young
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 20.09.2017
• Subjects: AMPK; beige adipocytes; farnesol; hAMSCs; obesity; Pharmacology; UCP1; UCP1; farnesol; AMPK; beige adipocytes; obesity; hAMSCs
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2017.00654

Brown adipocytes dissipate energy as heat and hence have an important therapeutic capacity for obesity. Development of brown-like adipocytes (also called beige) is also another attractive target for obesity treatment. Here, we investigated the effect of farnesol, an isoprenoid, on adipogenesis in adipocytes and on the browning of white adipose tissue (WAT) as well as on the weight gain of high-fat diet (HFD)-induced obese mice. Farnesol inhibited adipogenesis and the related key regulators including peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α through the up-regulation of AMP-activated protein kinase in 3T3-L1 murine adipocytes and human adipose tissue-derived mesenchymal stem cells (hAMSCs). Farnesol markedly increased the expression of uncoupling protein 1 and PPARγ coactivator 1 α in differentiated hAMSCs. In addition, farnesol limited the weight gain in HFD obese mice and induced the development of beige adipocytes in both inguinal and epididymal WAT. These results suggest that farnesol could be a potential therapeutic agent for obesity treatment.